CTTC currently has three active innovations that could in the future have an impact on the detection and treatment of heart disease. We are seeking commercialization and licensing partnership for these technologies.
Catheter Having Temperature Controlled Anchor and Related Methods
Assessment of Right Ventricular Function Using Contrast Echocardiography
New Drug for Blood Clot: FXII Inhibitors to Treat Thrombosis
CTTC also assisted Vanderbilt researchs in launching two startup companies using cardiac related technologies developed at Vanderbilt.
InvisionHeart - an ECG System that enables healthcare professionals to read and visually compare, confirm, report, store and manage their ECGs.
VenoStent - a vein graft-supporting device made from a new class of shape-memory polymers.